Mosquito larvae

Mosquito larvae represent the aquatic, immature developmental stage of mosquitoes within the family Culicidae. While not a molecular target such as a receptor or enzyme, they are the primary biological focus for larvicidal interventions aimed at controlling the transmission of vector-borne diseases like malaria, dengue, and Zika (CDC, 2020; WHO, 2021). The larvae progress through four instar stages, during which they are highly susceptible to chemical and biological agents that disrupt essential physiological processes. For instance, toxins from Bacillus thuringiensis israelensis (Bti) bind to receptors in the larval midgut, leading to pore formation and death (NIH, 2023). Other agents, such as methoprene, act as juvenile hormone analogs to prevent the transition to the adult stage, while chitin synthesis inhibitors like diflubenzuron interfere with the molting process (EPA, 2022). Effective larval management is a critical component of integrated pest management, though it requires monitoring for the emergence of resistance and assessing the ecological impact on non-target aquatic organisms (PubMed, 2019). Consequently, while "Mosquito larvae" is an organismal stage rather than a protein target, it remains the functional target for a wide array of public health chemistries.

Other names

Culicidae larvaeWrigglersMosquito immature stage

Larvicides disrupt physiological processes such as midgut membrane integrity (Bti), juvenile hormone signaling (Methoprene), chitin synthesis (Diflubenzuron), or neurotransmission (Temephos).